Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation

Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation

Background/Aims Finite nucleos(t)ide analog (NA) therapy has been proposed as an alternative treatment strategy for chronic hepatitis B (CHB), but biomarkers for post-treatment monitoring are limited. We investigated whether measuring hepatitis B core-related antigen (HBcrAg) after NA cessation may...

Full description

Bibliographic Details
Main Authors: Ying-Nan Tsai, Jia-Ling Wu, Cheng-Hao Tseng, Tzu-Haw Chen, Yi-Ling Wu, Chieh-Chang Chen, Yu-Jen Fang, Tzeng-Huey Yang, Mindie H. Nguyen, Jaw-Town Lin, Yao-Chun Hsu
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2024-01-01
Series:Clinical and Molecular Hepatology
Subjects:
chronic hepatitis b
antiviral treatment
finite nucleos(t)ide analog therapy
hepatitis b core-related antigen
Online Access:http://e-cmh.org/upload/pdf/cmh-2023-0194.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2023-0194.pdf

Similar Items